Dietary Cysteamine Research Articles

Impact of Dietary Supplementation of Cysteamine on Egg Taurine Deposition, Egg Quality, Production Performance and Ovary Development in Laying Hens.

This study aimed to examine the effect of dietary cysteamine on yolk taurine content in hens during different egg production periods. In Exp. 1, China Agricultural University-3 (CAU-3) hens at the peak stage of egg production (aged 31 wks) were used to explore the effect of diets supplemented with 0.1% cysteamine on yolk taurine content, egg quality and production performance. In Exp.2, two breeds of hens (half Hy-Line Brown and half CAU-3 hens) at the late stage of egg production (68 wks) were used to investigate the influence of diets supplemented with 0, 0.02%, 0.04%, 0.08% or 0.10% cysteamine on yolk taurine content, egg quality, production performance and ovary development. In Exp.1, diets supplemented with 0.1% cysteamine significantly increased yolk taurine content (p < 0.05) without negative influence on production performance or egg quality. In Exp.2, the highest yolk taurine content was observed when cysteamine was supplemented at 0.08% (p < 0.001). However, supplemental cysteamine linearly or quadratically decreased production performance over the first few weeks of feeding, and the effects disappeared with continued feeding (p < 0.05). In conclusion, this study indicated that cysteamine supplementation benefits yolk taurine deposition in hens at both peak and late stage of egg production, but hens at the late stage of egg production show depressed production performance and egg quality.

RETRACTED: Dietary cysteamine addition remarkably improved the growth performance and increased carcass protein deposition via inhibiting proteolysis-related genes in feedlot lambs

Cysteamine (CS), a metabolic product of coenzyme A in mammals, has been increasingly employed in China as a potential growth promoter in cattle and lamb feedlotting. This study was conducted to investigate the potential effects of CS on apparent nutrient digestibility, rumen methane fermentation, N metabolism, and slaughter performance. The experiment involved 48 male Dorper-Hu hybrid lambs with an initial live body weight of 33.32 ± 0.94 kg. These lambs were assigned to four dietary CS addition treatment groups with diets consisting of foxtail millet silage, corn straw, corn grain, soybean meal rapeseed meal, and different concentrations of CS (0, 20, 40, and 60 mg/kg body weight). The results showed that increasing dietary CS concentrations led to a linear increase in dry matter intake and average daily weight gain, as well as a quadratic increase in the apparent digestibility of dry matter, organic matter and crude protein (P < 0.05). Furthermore, increasing dietary CS concentrations linearly increased free fatty acids, growth hormone and insulin-like growth factor-I, while linearly decreased somatostatin levels (P < 0.01). In addition, increasing dietary CS concentrations linearly increased propionate but decreased acetate and methane prediction by 7.9–15.2% (P < 0.05). Based on the N balance measurement, increasing dietary CS concentrations quadratically increased daily N intake by 12.3% and daily N retention by 8.1–34.8% via reducing N loss efficiency in urine by 13.5% and in feces by 14.8% (P < 0.01). Dietary CS addition linearly increased the meat-to-bone ratio by 8.0–23.1% and lean yield by 6.4–22.2%; however, it decreased back tissue thickness (GR) by 8.7–11.3% and the fat-to-net meat yield ratio by 2.2–13.0% (P < 0.05). Furthermore, increasing dietary CS concentrations linearly increased the mRNA relative expression of insulin-like growth factors - I and protein kinase B (P < 0.05), while linearly decreased the relative mRNA expression of forkhead box protein o4, muscle ring finger 1, and muscle atrophy F-Box (P < 0.05). Cysteamine increased weight gain (+22.1%) via increasing feed intake and inhibiting somatostatin levels, and 40 mg/kg BW was determined to be the optimal dose for feeding. Furthermore, CS increased carcass protein deposition and decreased GR by inhibiting proteolysis, which improved carcass performance.

Dietary Cysteamine Supplementation Remarkably Increased Feed Efficiency and Shifted Rumen Fermentation toward Glucogenic Propionate Production via Enrichment of Prevotella in Feedlot Lambs.

Cysteamine (CS) is an essential nutritional regulator that improves the productive performance of animals by regulating somatotropic hormone secretion. To investigate the fattening potential and effects of CS on rumen microbial fermentation, 48 feedlot lambs were randomly assigned to four groups and fed diets supplemented with different CS concentrations (0, 20, 40, and 60 mg/kg BW). An increase in dietary CS concentrations linearly increased the average daily gain (ADG) and dry matter intake (p < 0.05) but decreased the feed-to-gain ratio (p < 0.01). For the serum hormone, increasing the dietary CS concentration linearly decreased somatostatin and leptin concentration (p < 0.01) but linearly increased the concentration of growth hormone and insulin-like growth factor 1 (p < 0.01). Regarding rumen fermentation, ruminal pH, ammonia-N, and butyrate content did not differ among the four treatments, although dietary CS supplementation linearly increased microbial protein and propionate and decreased the amount of acetate (p < 0.05). Furthermore, an increase in dietary CS concentrations quadratically decreased the estimated methane production and methane production per kg ADG (p < 0.05). High-throughput sequencing revealed that increased dietary CS concentrations quadratically increased Prevotella (p < 0.05), and Prevotella and norank_f__norank_o__Clostridia_UCG-014 were positively correlated with growth performance and rumen fermentation in a Spearman correlation analysis (r > 0.55, p < 0.05). Overall, a CS concentration higher than 20 mg/kg BW produced growth-promoting effects by inhibiting somatostatin concentrations and shifting the rumen toward glucogenic propionate fermentation by enriching Prevotella. In addition, Prevotella and norank_f__norank_o__Clostridia_UCG-014 were positively correlated with growth performance in lambs.

Effects of dietary cysteamine in quails on performance, hatchability, plasma biochemical and sex hormone levels

This study was designed to determine the effects of a single dose of dietary Cysteamine (Cys) on growth and laying performance, meat properties, hatchability, and plasma glucose, cholesterol, and sex hormone levels of quail in two experiments that followed each other. Trial 1 (T1): A total of two hundred, 1-d old quail (Coturnix coturnix japonica) chicks were randomly allocated to 1 of two treatment groups with 5 replicates, either a control group (basal diet) or a treatment group that contain 90 mg Cys per kg basal diet. During the 5 weeks growth period performance data regarding the growth period were collected. At the end of T1, a total of 30 quail were slaughtered, and color values, pH, and meat macronutrients were determined of breast meat. Data from T1 showed that the inclusion of 90 mg Cys in the diet did affect neither growth performance nor breast meat parameters of quail. Trial 2 (T2): At the end of T1, 40 from each treatment and a total of 80, six-weeks-old quail were selected randomly to use in the laying period experiment. Feeding with Cys added (90 mg/kg basal diet) and control (Basal) diets have been lasted in two treatment groups for 10 weeks for laying period. Laying and hatching performance data collected during T2, at the end of the trial, a total of 20 quails were sacrificed and plasma glucose, cholesterol, and sex hormone levels detected. Results of T2 displayed that 90 mg /kg feed dietary Cys increased egg mass (P&lt; 0.05), however, it was ineffective on other laying and hatching performance parameters. Whereas plasma glucose level was not altered, plasma cholesterol level significantly decreased with the presence of Cys in the diet (P&lt; 0.05). Moreover, dietary Cys significantly increased plasma sex hormones levels in both sexes. Concluded, 90 mg dietary Cys did not show an improving or depressing effect on the growth, laying, or hatching performance of quails however, its cholesterol-lowering impact and boosting effects on plasma sex hormones are noteworthy.

Maternal supply of cysteamine alleviates oxidative stress and enhances angiogenesis in porcine placenta

BackgroundOxidative stress in placenta is associated with the occurrence of adverse pregnancy outcomes in sow, but there are few satisfactory treatment strategies for these conditions. This study investigated the potential of cysteamine (CS) as an antioxidant protectant for regulating the reproductive performance, redox status, and placental angiogenesis of sows.MethodsThe placental oxidative stress status and vascular density of piglets with different birth weights: < 1.0 kg (low birth weight, LBW) and 1.4–1.6 kg (normal birth weight, NBW) were evaluated, followed by allotting 84 sows to four treatments (n = 21) and feeding them with a basal diet supplemented with 0, 100, 300, or 500 mg/kg of CS from d 85 of gestation to d 21 of lactation, respectively. Placenta, serum, and colostrum samples of sows or piglets were collected, and the characteristics of sows and piglets were recorded. Furthermore, the in vivo results were validated using porcine vascular endothelial cells (PVECs).ResultsCompared with the NBW placentae, the LBW placentae showed increased oxidative damage and were vulnerable to angiogenesis impairment. Particularly, H2O2-induced oxidative stress prompted intracellular reactive oxygen species generation and inhibited the tube formation and migration of PVECs as well as the expression of vascular endothelial growth factor-A (VEGF-A) in vitro. However, dietary CS supplementation can alleviate oxidative stress and improve the reproductive performance of sows. Specifically, compared with the control group, dietary 100 mg/kg CS could (1) decrease the stillbirth and invalid rates, and increase both the piglet birth weight in the low yield sows and the placental efficiency; (2) increase glutathione and reduce malondialdehyde in both the serum and the colostrum of sows; (3) increase the levels of total antioxidant capacity and glutathione in LBW placentae; (4) increase the vascular density, the mRNA level of VEGF-A, and the immune-staining intensity of platelet endothelial cell adhesion molecule-1 in the LBW placentae. Furthermore, the in vitro experiment indicated that CS pre-treatment could significantly reverse the NADPH oxidase 2-ROS-mediated inactivation of signal transducer and activator of transcription-3 (Stat3) signaling pathway induced by H2O2 inhibition of the proliferation, tube formation, and migration of PVECs. Meanwhile, inhibition of Stat3 significantly decreased the cell viability, tube formation and the VEGF-A protein level in CS pretreated with H2O2-cultured PVECs.ConclusionsThe results indicated that oxidative stress and impaired angiogenesis might contribute to the occurrence of LBW piglets during pregnancy, but CS supplementation at 100 mg/kg during late gestation and lactation of sows could alleviate oxidative stress and enhance angiogenesis in placenta, thereby increasing birth weight in low yield sows and reducing stillbirth rate. The in vitro data showed that the underlying mechanism for the positive effects of CS might be related to the activation of Stat3 in PVECs.

Cysteamine dioxygenase as enzymes for taurine synthesis and the negative effect of high dietary cysteamine on growth and body shape of the common carp, Cyprinus carpio

Cysteamine dioxygenase as enzymes for taurine synthesis and the negative effect of high dietary cysteamine on growth and body shape of the common carp, Cyprinus carpio

Effects of dietary crude protein levels and cysteamine supplementation on meat quality and related indices of finishing pigs

The aim of this study was to investigate the effects of dietary crude protein levels and cysteamine (CS) supplementation on meat quality and related indices in longissimus dorsi muscle of finishing pigs. One hundred and twenty barrows were randomly allocated to a 2 × 2 factorial arrangement with five replicates of six pigs each. The primary variations were crude protein levels (14% or 10%) and CS supplemental levels (0 or 140 mg kg−1). After 41 d, 10 pigs per treatment were slaughtered. The results showed that low-protein level diets (LPDs) decreased Warner–Bratzler shear force (P &lt; 0.01) and increased the content of intramuscular fat (P &lt; 0.01). The mRNA expressions of lipogenic genes were up-regulated (P &lt; 0.01), and the mRNA expressions of lipolytic genes were down-regulated (P &lt; 0.01) in pigs fed LPD. LPDs increased the mRNA expressions of μ-calpain, and decreased the mRNA expression of calpastatin (P &lt; 0.01). In addition, CS supplementation increased the mRNA expression of μ-calpain (P &lt; 0.01). In conclusion, LPD improved the meat quality probably through regulating the lipogenesis, lipolysis, and the proteolysis process in muscle. The CS supplementation did not affect the meat quality of finishing pigs. Moreover, no significant interaction between dietary protein levels and CS supplementation for the meat quality of finishing pigs was observed.

Dietary cysteamine hydrochloride protects against oxidation, inflammation, and mucosal barrier disruption of broiler chickens challenged with Clostridium perfringens.

This study aimed to investigate the effect of dietary cysteamine hydrochloride (CSH) on the growth performance, oxidation, inflammation, and gene expression of cytoskeleton and tight junction in the intestinal mucosa of broiler chickens challenged with Clostridium perfringens (C. perfringens). A total of 360 one-day-old broiler chicks were randomly distributed into 5 groups for a negative control (NC, without C. perfringens challenge), a positive control (PC, with C. perfringens challenge), and PC plus CSH at 100, 150, or 200 mg/kg of diet. The results showed that average daily gain, gain:feed, cecal population and enterotoxin of C. perfringens were negatively affected (P < 0.05) by the C. perfringens challenge, but were conversely affected (P < 0.05) by the CSH supplementation, and G:F reached to the level of NC group. The PC group increased (P < 0.05) serum diamine oxidase, malondialdehyde, protein carbonyl, interleukin-6, interleukin-1β, and tumor necrosis factor-α, whereas the supplementation of CSH decreased (P < 0.05) these parameters. Moreover, the C. perfringens challenge worsened the disruption of intestinal mucosal cytoskeleton and tight junction by downregulating (P < 0.05) the mRNA levels of actin protein of muscle Z-line alpha, syncoilin, synemin, tubulin, claudin-1, and zona occludens protein-2, while these parameters were partially compensated (P < 0.05) by CSH supplementation. For the dose trends of CSH, there were linear and quadratic (P < 0.05) effects on gain:feed, enterotoxins, tumor necrosis factor-α, tubulin alpha 1c, syncoilin, and synemin. In conclusion, the CSH can be an alternative against C. perfringens infection by beneficially regulating gut pathogenic bacteria and enterotoxins, oxidation, inflammation, cytoskeleton, and tight junction in broiler chickens.

Effects of Dietary Crude Protein Levels and Cysteamine Supplementation on Protein Synthetic and Degradative Signaling in Skeletal Muscle of Finishing Pigs.

Dietary protein levels and cysteamine (CS) supplementation can affect growth performance and protein metabolism of pigs. However, the influence of dietary protein intake on the growth response of CS-treated pigs is unclear, and the mechanisms involved in protein metabolism remain unknown. Hence, we investigated the interactions between dietary protein levels and CS supplementation and the effects of dietary crude protein levels and CS supplementation on protein synthetic and degradative signaling in skeletal muscle of finishing pigs. One hundred twenty barrows (65.84 ± 0.61 kg) were allocated to a 2 × 2 factorial arrangement with five replicates of six pigs each. The primary variations were dietary crude protein (CP) levels (14% or 10%) and CS supplemental levels (0 or 700 mg/kg). The low-protein (LP) diets (10% CP) were supplemented with enough essential amino acids (EAA) to meet the NRC AA requirements of pigs and maintain the balanced supply of eight EAA including lysine, methionine, threonine, tryptophan, valine, phenylalanine, isoleucine, and leucine. After 41 days, 10 pigs per treatment were slaughtered. We found that LP diets supplemented with EAA resulted in decreased concentrations of plasma somatostatin (SS) (P<0.01) and plasma urea nitrogen (PUN) (P<0.001), while dietary protein levels did not affect other traits. However, CS supplementation increased the average daily gain (P<0.001) and lean percentage (P<0.05), and decreased the feed conversion ratio (P<0.05) and back fat (P<0.05). CS supplementation also increased the concentrations of plasma insulin-like growth factor 1 (IGF-1) (P<0.001), and reduced the concentrations of leptin, SS, and PUN (P<0.001). Increased mRNA abundance of Akt1 and IGF-1 signaling (P<0.001) and decreased mRNA abundance of Forkhead Box O (FOXO) 4 (P<0.01) and muscle atrophy F-box (P<0.001) were observed in pigs receiving CS. Additionally, CS supplementation increased the protein levels for the phosphorylated mammalian target of rapamycin (mTOR), eIF-4E binding protein 1, and ribosomal protein S6 kinase 1 (P<0.001). There were no interactions between dietary protein levels and CS supplementation for all traits. In conclusion, dietary protein levels and CS supplementation influenced growth and protein metabolism through independent mechanisms in pigs. In addition, LP diets supplemented with EAA did not affect growth performance and other traits except the concentrations of SS and PUN probably through maintenance of protein synthesis and degradation signaling. Moreover, CS supplementation improved growth performance by increasing plasma IGF-1 concentrations possibly through alterations of mTOR and Akt/FOXO signaling pathways in skeletal muscle of finishing pigs.

Effect of cysteamine hydrochloride supplementation on the milk performance of dairy cow

Cysteamine (CS) can increase serum growth hormone concentrations and the growth performance of broiler, sheep, and pigs. However, information of CS supplementation on the milk performance of dairy cows is limited. An experiment was conducted to investigate the effect of dietary cysteamine hydrochloride (CSH) supplementation on lactation performance of dairy cows. Forty-eight multiparous mid-lactation Holsteins were fed a control diet or supplemented with 15, 30, or 45g/d CSH preparation (cysteamine HCl 20%) for 63d, including 7d for adaptation. The base diet was formulated to meet the nutrient requirements of lactating dairy cows according to the Chinese feeding standard (China Standard NY/T 34,Feeding standard of dairy cattle 2004 Issued by Ministry of Agriculture of People's Republic of ChinaBeijing) and the DMI, milk yield, milk composition, and plasma parameters were measured. Milk yield was 7.1% and 6.3% higher for the two higher supplementation amounts (SEM=0.50, P<0.05), and milk protein content was 7.7%, 8.7%, and 8.1% higher for the three supplemented groups (SEM=0.077, P<0.05), respectively, than the control. Plasma urea N were lower for the 30 and 45g/d CSH groups than for the control. Level of plasma somatostation was reduced and plasma growth hormone was enhanced in CSH groups compared with that of control (P<0.01). Supplementation of CSH preparation at 30g/d increased milk production of dairy cows while 15g/d has no positive effect on milk yield or milk efficiency.

Cysteamine improves growth performance and gastric ghrelin expression in preweaning piglets

The aim of the present study was to investigate the effect of cysteamine on growth performance of preweaning piglets and gastric expression of ghrelin mRNA in vivo and in vitro. Twelve litters of newborn piglets were allocated randomly to control and treatment groups. From 15 d of age, piglets in the control group were fed basal creep diet, whereas the treatment group received basal diet supplemented with 120 mg cysteamine per kg of diet until weaning on 35 d of age. Body weight gain, creep feed consumption, and diarrhea rates were recorded, and gastric mucosal tissues were collected for quantifying mRNA expression. To evaluate the direct effect of cysteamine on gastric ghrelin expression, primary cultures of gastric mucosal cells isolated from 35-d-old piglets were exposed to cysteamine for 20 h at 0, 1, 10, and 100 μg/mL, respectively. Dietary cysteamine increased (P < 0.05) average daily creep feed consumption and BW gain in preweaning pigs, which was accompanied by reduction in diarrhea rates. At 35 d of age, piglets treated with cysteamine showed increased (P < 0.05) ghrelin and gastrin and decreased (P < 0.05) somatostatin mRNA expression in gastric mucosa. Moreover, dietary cysteamine treatment increased serum concentration of gastrin (P < 0.05). In vitro, cysteamine significantly increased ghrelin mRNA expression in gastric mucosal cells at the concentration of 10 μg/mL. In conclusion, dietary cysteamine is effective in improving the growth performance and health condition of preweaning piglets, which is associated with its stimulatory effects on gastric ghrelin mRNA expression both in vivo and in vitro.

Effects of dietary cysteamine supplementation on growth performance and whole-body protein turnover in finishing pigs

The objective of this study was to investigate the effects of dietary cysteamine (CS) supplementation on growth performance and whole-body protein turnover in finishing pigs. This experiment contained 2 trials with the first trial of effect of dietary cysteamine supplementation on growth performance in finishing pigs for 47 d. A total of 16 PIC pigs (60.02 ± 1.01 kg; eight gilts and eight barrows) were randomly assigned to one of two dietary groups, with four pens per group (per pen: one gilt, one barrow). In the second trial, a total of eight PIC barrows (60.04 ± 1.02 kg) were randomly assigned to one of the two dietary groups, with four pens/group (one pig/pen) for 37 d and then the eight barrows were housed individually in metabolism crates (four barrows in control group and four barrows in CS group) for 10 d. The pigs of the first and second trials were fed a basal diet containing 0 (control) or 70 mg CS/kg diet. A total of eight barrows of the second trial received a 7-d nitrogen balance trial. 15 N-Glycine (10 mg/kg BW) was gastrically infused after d 5 of the nitrogen balance trial. Feces and urine were collected daily to determine the N output. Results indicated that CS supplementation increased ( P < 0.05) average daily gain (ADG), feed intake (ADFI), nitrogen retention, nitrogen retention efficiency, and efficiency of digestible N utilization. In addition, CS supplementation resulted in a decreased ( P < 0.05) protein breakdown rate. Net protein gain in nitrogen was increased ( P < 0.05) by 63.5%. However, protein synthesis rate, nitrogen flux, and endogenous urinary nitrogen were not affected ( P > 0.05). It is concluded that dietary CS supplementation may improve growth performance in finishing pigs. Protein deposition is increased after dietary CS supplementation. This increase is caused by a decrease in protein breakdown.

Tissue-Specific Effect of Dietary Cysteamine on Expression of Adiponectin Receptors in Rats

Adiponectin is synthesized by adipocytes and affects glucose and lipid metabolism by binding to its receptors, AdipoR1 and AdipoR2. Cysteamine, a naturally existing intermediate metabolite of sulfur amino acid, has been reported to modulate metabolism and growth in various species of animals; however, whether the action of cysteamine involves adiponectin and its receptors is unknown. The objective of the present study was therefore to investigate the effect of dietary cysteamine on the expression of AdipoR1/R2 in different tissues, in association with the alterations in endocrine and metabolic status. Rats were fed either of the diets supplemented with 0 or 700 mg/kg cysteamine feed additive (containing 30% of cysteamine hydrochloride) for 4 weeks, and the expression of adiponectin and its receptors in adipose tissue, AdipoR1 and AdipoR2 in liver, gastrocnemius, and soleus muscle was determined, in association with the growth performance and serum concentrations of hormones and metabolites. A temporal trend of increase in growth rate and the ratio of feed consumption relative to body weight gain was observed in the second week of cysteamine supplementation. Serum concentrations of insulin and TNF-alpha increased, while serum levels of triglycerides, FFA, and total cholesterol decreased significantly 4 weeks after cysteamine treatment. Leptin and GH remained unaffected. Cysteamine supplementation increased mRNA expression of AdipoR1 in adipose tissue, gastrocnemius, and soleus muscle as well as that of AdipoR2 in soleus muscle and adipose tissue. Nevertheless, hepatic expression of AdipoR1 and AdipoR2 was not influenced. Despite a numeric increase, no significant alteration in adiponectin mRNA expression in adipose tissue was observed. In conclusion, dietary supplementation of cysteamine modulates the endocrine and metabolic status of rats, which may involve the tissue-specific responses of adiponectin receptors at the level of mRNA transcription.